|
|
|
|
|
|
|
|
|
|
| Email |
jprudhomme@ibcusa.com
|
|
| Category |
Science: Chemistry
|
|
| Category 2 |
Science: Life_Sciences
|
|
|
|
|
|
| Contact |
One Research Drive
Suite 400A
Westborough, MA 01581-5195
|
|
|
|
|
|
| Description |
Post-translational modifications of recombinant therapeutic proteins present the biotechnology industry with some of its most complex and current challenges in production, manufacture, and analysis of such therapeutics. Recognizing the biological significance of post-translational modifications and its associated economic impact to the industry, IBC has brought together industry and academic leaders to share their experiences at a unique conference. IBC’s The Impact of Post-Translational & Chemical Modifications on Protein Therapeutics is the only conference where you can learn how to exploit post-translational changes for improving your therapeutic protein and understand how to prevent costly delays caused by unwanted modifications.
|
|
|
|
